Explore common pharmacist concerns about generic substitution, including clinical risks with NTI drugs, patient mistrust, and educational burdens. Learn strategies to improve acceptance and ensure safe practice.
read more
Explore how international policies and practices shape the global generics market, from U.S. high-penetration models to China's bulk procurement and EU regulations.
read more
Cmax and AUC are the two key pharmacokinetic measures used to prove generic drugs work the same as brand-name versions. They track peak concentration and total exposure - and both must fall within strict limits to ensure safety and effectiveness.
read more